Scientific World

Speech and Hearing Tests Enable Early Detection of Rare Language-Based Dementia

A recent study supported by FAPESP and published in PLOS ONE has revealed that primary progressive aphasia (PPA), a rare and aggressive form of dementia that begins with language impairments, can be detected early using a specialized battery of speech and hearing tests. The research, led by Karin Zazo Ortiz of the Federal University of São Paulo (UNIFESP), highlights the potential for earlier diagnosis and intervention, which could slow disease progression and preserve communication skills longer.

Primary progressive aphasia is a neurodegenerative disease that initially manifests as difficulty finding words, forming sentences, or reading and writing. Unlike aphasia caused by strokes or brain injuries, PPA is linked to frontotemporal brain degeneration and is often misdiagnosed due to its similarity to other dementia syndromes like Alzheimer’s.

The study evaluated 87 individuals, including 29 diagnosed with PPA, using the Montreal-Toulouse Language Assessment Battery (MTL-BR). This comprehensive test identified significant differences in performance between healthy participants and those with PPA, particularly in tasks involving sentence comprehension, verbal fluency, and written expression.

“Early diagnosis is crucial because it allows for timely rehabilitation, which can help patients maintain their communication abilities for longer,” explained Ortiz. The team is now working to pinpoint the most effective tests for identifying specific PPA subtypes, which include non-fluent, semantic, logopenic, and mixed variants.

Dr. Ortiz emphasized, “Our study provides a practical tool for distinguishing PPA from other dementias, addressing a critical gap in language assessment for neurodegenerative diseases.”

The findings offer hope for improved early detection of PPA, enabling better management of the disease. Future research will focus on refining diagnostic tools to accommodate the diverse presentations of PPA, ultimately aiding clinicians and patients in navigating this challenging condition.

Add comment